CLPT
ClearPoint Neuro, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.09
+3.96%Next report
Analyst consensus
- Next report date
- Mar 16, 2027
- EPS estimate
- -$0.23
- Revenue estimate
- $13.2M
Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- -$0.24
- EPS estimate
- -$0.32
- Revenue actual
- $12.1M
- Revenue estimate
- $12.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -15.1%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | -$0.32 | -$0.24 | Beat 23.81% | $12.1M |
| Aug 3, 2026 | -$0.29 | -$0.38 | Miss -32.56% | $10.9M |
| May 13, 2026 | -$0.28 | -$0.32 | Miss -14.29% | $12.1M |
| Mar 17, 2026 | -$0.20 | -$0.27 | Miss -37.49% | $10.4M |
| Nov 6, 2025 | -$0.20 | -$0.21 | Miss -5.00% | $8.9M |
| Feb 26, 2025 | -$0.15 | -$0.20 | Miss -33.33% | $7.8M |
| Nov 7, 2024 | -$0.17 | -$0.18 | Miss -5.88% | $8.1M |
| Mar 12, 2024 | -$0.22 | -$0.19 | Beat 13.64% | $6.8M |
| Nov 9, 2023 | -$0.25 | -$0.20 | Beat 20.00% | $5.8M |
| May 11, 2023 | -$0.18 | -$0.23 | Miss -27.78% | $5.4M |
| Mar 1, 2023 | -$0.22 | -$0.18 | Beat 18.18% | $5.2M |
| Aug 9, 2022 | -$0.18 | -$0.18 | In line | $5.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 16, 2027